ML20282A514

Exubrion Procedure for Use of Synovetin Oa

ML20282A514
Person / Time
Issue date:	06/01/2020
From:	Exubrion Therapeutics
To:	Office of Nuclear Material Safety and Safeguards
Katie Tapp
Shared Package
ML20282A513	List: ML20282A514 ML20282A515
References
Download: ML20282A514 (11)